Bioorganic & Medicinal Chemistry Letters 2009-01-15

Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.

W Edward Martucci, Marina Udier-Blagovic, Chloe Atreya, Oladapo Babatunde, Melissa A Vargo, William L Jorgensen, Karen S Anderson

Index: Bioorg. Med. Chem. Lett. 19 , 418-23, (2009)

Full Text: HTML

Abstract

The essential enzyme thymidylate synthase-dihydrofolate reductase (TS-DHFR) is a validated drug target for many pathogens, but has been elusive in Cryptosporidium hominis, as active site inhibitors of the enzymes from related parasitic protozoa show decreased potency and lack of species specificity over the human enzymes. As a rational approach to discover novel inhibitors, we conducted a virtual screen of a non-active site pocket in the DHFR linker region. From this screen, we have identified and characterized a noncompetitive inhibitor, flavin mononucleotide (FMN), with micromolar potency that is selective for ChTS-DHFR versus the human enzymes. These results describe a novel allosteric pocket amenable to inhibitor targeting, and a lead compound with which to move towards potent, selective inhibitors of ChTS-DHFR.